| MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms YN Liu, JJ Yin, W Abou-Kheir, PG Hynes, OM Casey, L Fang, M Yi, ... Oncogene 32 (3), 296-306, 2013 | 352 | 2013 |
| Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition YN Liu, W Abou-Kheir, JJ Yin, L Fang, P Hynes, O Casey, D Hu, Y Wan, ... Molecular and cellular biology 32 (5), 941-953, 2012 | 187 | 2012 |
| Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells HF Bahmad, K Cheaito, RM Chalhoub, O Hadadeh, A Monzer, F Ballout, ... Frontiers in oncology 8, 347, 2018 | 180 | 2018 |
| EGF receptor promotes prostate cancer bone metastasis by downregulating miR-1 and activating TWIST1 YS Chang, WY Chen, JJ Yin, H Sheppard-Tillman, J Huang, YN Liu Cancer research 75 (15), 3077-3086, 2015 | 109 | 2015 |
| MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer WY Chen, SY Liu, YS Chang, JJ Yin, H Yeh, TH Mouhieddine, ... Oncotarget 6 (1), 441, 2015 | 106 | 2015 |
| Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition P Martin, YN Liu, R Pierce, W Abou-Kheir, O Casey, V Seng, D Camacho, ... The American journal of pathology 179 (1), 422-435, 2011 | 104 | 2011 |
| Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway MK Siu, YC Tsai, YS Chang, JJ Yin, F Suau, WY Chen, YN Liu Oncogene 34 (36), 4767-4776, 2015 | 96 | 2015 |
| Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer WY Chen, YC Tsai, HL Yeh, F Suau, KC Jiang, AN Shao, J Huang, YN Liu Science signaling 10 (492), eaam6826, 2017 | 65 | 2017 |
| Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance MK Siu, W Abou-Kheir, JJ Yin, YS Chang, B Barrett, F Suau, O Casey, ... Oncotarget 5 (11), 3770, 2014 | 65 | 2014 |
| AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasis JJ Yin, YN Liu, H Tillman, B Barrett, S Hewitt, K Ylaya, L Fang, R Lake, ... Cancer research 74 (16), 4306-4317, 2014 | 58 | 2014 |
| Loss of androgen-regulated microRNA 1 activates SRC and promotes prostate cancer bone metastasis YN Liu, JJ Yin, B Barrett, H Sheppard-Tillman, D Li, OM Casey, L Fang, ... Molecular and cellular biology, 2015 | 53 | 2015 |
| Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2 YC Tsai, WY Chen, W Abou-Kheir, T Zeng, JJ Yin, H Bahmad, YC Lee, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (5 …, 2018 | 52 | 2018 |
| Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells R El-Merahbi, YN Liu, A Eid, G Daoud, L Hosry, A Monzer, ... PLoS One 9 (11), e112453, 2014 | 45 | 2014 |
| Leukemia inhibitory factor promotes castration-resistant prostate cancer and neuroendocrine differentiation by activated ZBTB46 YN Liu, S Niu, WY Chen, Q Zhang, Y Tao, WH Chen, KC Jiang, X Chen, ... Clinical Cancer Research 25 (13), 4128-4140, 2019 | 38 | 2019 |
| Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis WY Chen, YC Tsai, MK Siu, HL Yeh, CL Chen, JJ Yin, J Huang, YN Liu Oncogene 36 (45), 6213-6224, 2017 | 36 | 2017 |
| Self-renewing Pten-/-TP53-/-protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity W Abou-Kheir, PG Hynes, P Martin, JJ Yin, YN Liu, V Seng, R Lake, ... PloS one 6 (10), e26112, 2011 | 36 | 2011 |
| MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB S Niu, X Ma, Y Zhang, YN Liu, X Chen, H Gong, Y Yao, K Liu, X Zhang PLoS One 13 (2), e0192790, 2018 | 35 | 2018 |
| Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6 YC Tsai, WY Chen, MK Siu, HY Tsai, JJ Yin, J Huang, YN Liu Cancer letters 384, 1-8, 2017 | 33 | 2017 |
| Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance WY Chen, YC Wen, SR Lin, HL Yeh, KC Jiang, WH Chen, YS Lin, ... Communications biology 4 (1), 22, 2021 | 29 | 2021 |
| EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer SR Lin, YC Wen, HL Yeh, KC Jiang, WH Chen, N Mokgautsi, J Huang, ... Oncogene 39 (44), 6757-6775, 2020 | 29 | 2020 |
